Parthasarathi succeeds Rob Lindberg, who has become director of the NC Biotechnology Center’s Business Acceleration and Technology Out-Licensing Network, known as BATON, startup-business-support program, which is also part of the Business and Technology Development unit.
Joel McComb, Gregory Heath, Shobha Parthasarathi, Rob Lindberg
Illumina this week announced the appointment of Joel McComb as senior vice president and general manager of the company's life sciences business unit and Gregory Heath as senior vice president and general manager of the company's diagnostics business unit.
McComb joins Illuminafrom GE Healthcare where he held a number of executive positions, and most recently was president of the interventional medicine business. McComb was previously president of the Life Sciences Discovery Systems division of GE Healthcare. Prior to GE Healthcare, McComb was president and CEO of Innovadyne Technologies.
From 1995 to 2001, McComb held various positions at Beckman Coulter, including roles as general manager of the primary care diagnostic division and director of corporate business development.
Heath, meantime, joins Illumina from Roche Molecular Systems, where he held a number of positions, including head of clinical genomics, senior vice president of global product marketing, senior vice president of global marketing and business development, and most recently, senior vice president of global business.
From 2000 to 2003, Heath was head of business development and licensing for the diagnostics division of F. Hoffman La Roche in Basel and led the strategic planning, business development and licensing activities of the molecular diagnostics, centralized diagnostics, applied science, near patient testing, and diabetes care business areas.
Prior to this, Heath held various roles in marketing and business development with Roche Diagnostics.
Shobha Parthasarathi has joined the North Carolina Biotechnology Center as technology development director in the Business and Technology Development unit, the center announced this week.
Parthasarathi was previously a senior researcher and manager at Millennium Pharmaceuticals, where she conducted drug discovery research, evaluated technologies, and developed in-house expertise for multiple therapeutic groups.